Takeda is a patient-focused, values-based, global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Takeda fosters a collaborative and stimulating work environment driven by integrity. 

With diversified colleagues around the world, a strong growth strategy, and a reputation built on outstanding values and a history of success, Takeda is a pharmaceutical industry leader. As a member of our team, you will be empowered to build better solutions, be part of world-class research and development, and take on career development opportunities.

Here, you will be a vital contributor to our inspiring, bold mission

The R&D Center for Health Equity and Patient Affairs is a core pillar of the Chief Medical Office (CMO) and builds on the CMO’s holistic, inclusive and patient focused approach and deliberately links to R&D imperatives related to the Inclusive Ecosystem pillar of our diversity, equity and inclusion (DE&I) strategy. 

The Head of R&D Center for Health Equity and Patient Affairs will provide oversight for the following Centers of Excellence (CoE) and is responsible for creating a unifying vision and strategy for R&D’s end-to-end patient focused approach in alignment with R&D priorities with a focus on global health equity, development of and equitable access to meaningful therapeutic options and improved diagnosis:

•    R&D Health Equity:  Creates and maintains a unifying vision and strategy for how Takeda can address health disparities, improve health equity globally, and work in close partnership with other DE&I stakeholders. This function will work across Takeda to embed health equity principles within the company and position us as an industry leader in this effort. 

•    Named Patient Programs (NPP): Leads planned programs that enable an eligible patient to receive a Takeda products for the lead indication prior to local commercial availability in countries where there is an intent to commercialize. 

•    Individual Patient Requests (IPR): Works with GPTs when HCPs make unsolicited requests for a Takeda investigational product that falls outside the scope of an NPP. This group will work closely with NPP. 

•    R&D Patient Engagement Office (PEO): Collaborates with key internal and external stakeholders throughout the development lifecycle to capture patient insights and ensure these insights shape development plans. 

•    Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease: The Global Commission, co-founded by Takeda, harnesses the power of technology and empowering families to accelerate the time to diagnose a child with a rare disease.

Importantly, in order to build a more inclusive ecosystem, the Head of R&D Center for Health Equity and Patient Affairs will be responsible for building and leading internal and external networks to position Takeda as a leader in health equity in close collaboration with cross-functional partners. 

ACCOUNTABILITIES

•    Lead and provide strategic oversight for a newly formed R&D Center for Health Equity and Patient Affairs to integrate and align the R&D Center for Health Equity and Patient Affairs core CoE’s, ensuring integration and execution of the R&D Center for Health Equity and Patient Affairs activities to maximize value across R&D and the broader Takeda enterprise.
•    Establish infrastructure, resources, programming and partnerships to support successful implementation of CoE strategies.
•    Build and develop a diverse, industry-leading R&D Center for Health Equity and Patient Affairs team through coaching, training, leadership development and effective recruitment and retention strategies.
•    Empower, advise and support the R&D Center for Health Equity and Patient Affairs leadership team to deliver on short and long-term goals and objectives specific to each of the CoE’s (Health Equity, Patient Engagement, Early Access and Early Diagnosis of Rare Disease).
•    Ensure state of the art integrated early access and post-trial access policy and its consistent implementation on a Takeda enterprise level and alignment with Access to Medicines program as well as Regional / LOC approaches.  
•    Provide medical expertise and consultation on early access programs. Represent Takeda internally externally related to access policies and individual access decisions as needed. 
•    Partner effectively across R&D functions, Business Units and other divisions to enhance connectivity, address emerging issues, align on priorities and manage expectations.
•    Represent the R&D Center for Health Equity and Patient Affairs on CMO LT, executive level R&D and cross-organizational leadership teams and governance bodies.
•    Collaborate with the Head of R&D Health Equity, R&D leaders and Business Units to build and lead a diverse inclusive ecosystem of patients, partners and communities to strengthen health research, access and capacity building in an effort to address health inequalities globally.
•    Champion R&D diversity, equity and inclusion strategies. 
•    Oversee the R&D Center for Health Equity and Patient Affairs budget planning & execution and communication of milestones & KPIs to Takeda leadership. 
•    Proactively identify and prioritize opportunities and partnerships to position Takeda as an industry leader in health equity and patient focused approach.
•    Spearhead internal and external efforts and policy development related the overseen functions.
•    Represent CMO and Takeda at Regulatory Agencies, Patient Association Meetings, Consortia and other external venues.

FOR FULL JOB DESCRIPTION, PLEASE VISIT TAKEDA CAREERS WEBSITE: https://takeda.wd3.myworkdayjobs.com/External/job/Boston-MA/Head-of-R-D-Center-for--Health-Equity-and-Patient--Affairs_R0024730-2